Ariella Kelman, MD

Dr. Ariella Kelman brings nearly 20 years of experience in immunology clinical development to her role of Chief Medical Officer of TRexBio. Previously, Dr. Kelman served as Chief Medical Officer at Biora Therapeutics, and before that, she led clinical development at Human Immunology Biosciences. Prior to that, Dr. Kelman spent 15 years at Genentech/Roche, where she led clinical development programs for several new medicines for inflammatory and autoimmune diseases and subsequently served as global head of bioethics for Roche.

Dr. Kelman was an attending physician for 10 years in the Division of Immunology and Rheumatology at Stanford University Hospital. Dr. Kelman holds a BS from UCLA, and an MD from Tel Aviv University. She completed her residency in internal medicine at Kaiser Hospitals in Los Angeles and Santa Clara and completed fellowships in rheumatology and clinical research at Stanford University Hospital.